These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27116333)

  • 1. To wake up cancer stem cells, or to let them sleep, that is the question.
    Takeishi S; Nakayama KI
    Cancer Sci; 2016 Jul; 107(7):875-81. PubMed ID: 27116333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cell cycle regulation in cancer stem cells].
    Takeishi S
    Nihon Rinsho; 2015 May; 73(5):779-83. PubMed ID: 25985630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Fbxw7 in the maintenance of normal stem cells and cancer-initiating cells.
    Takeishi S; Nakayama KI
    Br J Cancer; 2014 Sep; 111(6):1054-9. PubMed ID: 24853181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
    Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
    Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
    Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
    Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells.
    Lee SH; Reed-Newman T; Anant S; Ramasamy TS
    Stem Cell Rev Rep; 2020 Dec; 16(6):1185-1207. PubMed ID: 32894403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of FBXW7 in the quiescence of gefitinib-resistant lung cancer stem cells in EGFR-mutant non-small cell lung cancer.
    Hidayat M; Mitsuishi Y; Takahashi F; Tajima K; Yae T; Miyahara K; Hayakawa D; Winardi W; Ihara H; Koinuma Y; Wirawan A; Nurwidya F; Kato M; Kobayashi I; Sasaki S; Takamochi K; Hayashi T; Suehara Y; Moriyama M; Moriyama H; Habu S; Takahashi K
    Bosn J Basic Med Sci; 2019 Nov; 19(4):355-367. PubMed ID: 31202256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
    Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
    J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
    Wei S; Lin LF; Yang CC; Wang YC; Chang GD; Chen H; Chen CS
    Mol Pharmacol; 2007 Sep; 72(3):725-33. PubMed ID: 17569795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fbxw7 in cell cycle exit and stem cell maintenance: insight from gene-targeted mice.
    Onoyama I; Nakayama KI
    Cell Cycle; 2008 Nov; 7(21):3307-13. PubMed ID: 18948752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles for the FBXW7 ubiquitin ligase in leukemia and beyond.
    Kourtis N; Strikoudis A; Aifantis I
    Curr Opin Cell Biol; 2015 Dec; 37():28-34. PubMed ID: 26426760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance.
    Chen K; Zhang C; Ling S; Wei R; Wang J; Xu X
    Cell Death Dis; 2021 Sep; 12(9):835. PubMed ID: 34482364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance.
    Makena MR; Ranjan A; Thirumala V; Reddy AP
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165339. PubMed ID: 30481586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies targeting cancer stem cells.
    Yoshida GJ; Saya H
    Cancer Sci; 2016 Jan; 107(1):5-11. PubMed ID: 26362755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategies targeting cancer stem cells.
    Ning X; Shu J; Du Y; Ben Q; Li Z
    Cancer Biol Ther; 2013 Apr; 14(4):295-303. PubMed ID: 23358473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical and therapeutic implications of cancer stem cell biology.
    Cheng L; Alexander R; Zhang S; Pan CX; MacLennan GT; Lopez-Beltran A; Montironi R
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):1131-43. PubMed ID: 21806335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Stem Cells and Targeting Strategies.
    Barbato L; Bocchetti M; Di Biase A; Regad T
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.